| scholarly article | Q13442814 |
| P2093 | author name string | Vytas K Verselis | |
| Miduturu Srinivas | |||
| P2860 | cites work | Quinine blocks specific gap junction channel subtypes | Q24555201 |
| Calcium block of Na+ channels and its effect on closing rate | Q24646976 | ||
| Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant | Q24675998 | ||
| Gap junctions in inherited human disorders of the central nervous system | Q26823332 | ||
| Structure of the connexin 26 gap junction channel at 3.5 A resolution | Q27654539 | ||
| Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases | Q28267180 | ||
| Ionic blockade of the rat connexin40 gap junction channel by large tetraalkylammonium ions | Q28365137 | ||
| Effects of connexin-mimetic peptides on gap junction functionality and connexin expression in cultured vascular cells | Q28573218 | ||
| Tales of a Dirty Drug: Carbenoxolone, Gap Junctions, and Seizures | Q28972313 | ||
| Emerging issues of connexin channels: biophysics fills the gap. | Q30167614 | ||
| The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome | Q30428153 | ||
| Two distinct gating mechanisms in gap junction channels: CO2-sensitive and voltage-sensitive | Q33915425 | ||
| Differentially altered Ca2+ regulation and Ca2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis ichthyosis deafness syndrome | Q33950693 | ||
| Hemichannel and junctional properties of connexin 50. | Q34177646 | ||
| Voltage-dependent blockade of connexin40 gap junctions by spermine | Q34180081 | ||
| Effect of external magnesium and calcium on human connexin46 hemichannels | Q34180119 | ||
| Correlative studies of gating in Cx46 and Cx50 hemichannels and gap junction channels | Q34189343 | ||
| Triarylmethanes, a new class of cx50 inhibitors | Q34299455 | ||
| Human connexin channel specificity of classical and new gap junction inhibitors | Q34333979 | ||
| Block of specific gap junction channel subtypes by 2-aminoethoxydiphenyl borate (2-APB). | Q34567249 | ||
| Prospects for rational development of pharmacological gap junction channel blockers | Q35007602 | ||
| The antimalarial agent mefloquine inhibits ATP-sensitive K-channels | Q35042825 | ||
| The combinatorial synthesis of bicyclic privileged structures or privileged substructures. | Q35083549 | ||
| Electrical coupling and excitatory synaptic transmission between rhythmogenic respiratory neurons in the preBötzinger complex | Q35111858 | ||
| Mechanism for modulation of gating of connexin26-containing channels by taurine | Q35208333 | ||
| Molecular dynamics simulations of the Cx26 hemichannel: evaluation of structural models with Brownian dynamics | Q35503280 | ||
| Mechanism of inhibition of connexin channels by the quinine derivative N-benzylquininium | Q35647366 | ||
| Selective optimization of side activities: another way for drug discovery | Q35681235 | ||
| Gap junction channel gating | Q35700096 | ||
| Pore-lining residues identified by single channel SCAM studies in Cx46 hemichannels | Q35892064 | ||
| Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide | Q36057140 | ||
| Lens gap junctions in growth, differentiation, and homeostasis. | Q36233134 | ||
| Pharmacology of gap junctions. New pharmacological targets for treatment of arrhythmia, seizure and cancer? | Q36282330 | ||
| Gap junction remodeling and cardiac arrhythmogenesis in a murine model of oculodentodigital dysplasia. | Q36300072 | ||
| How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease? | Q36368553 | ||
| Kinetic properties of a voltage-dependent junctional conductance | Q36408444 | ||
| Equilibrium properties of a voltage-dependent junctional conductance. | Q36408460 | ||
| The role of stem cells and gap junctions as targets for cancer chemoprevention and chemotherapy | Q36409372 | ||
| Properties of a nonjunctional current expressed from a rat connexin46 cDNA in Xenopus oocytes | Q36435171 | ||
| Structure-activity relations of the cardiac gap junction channel | Q36559690 | ||
| Divalent cations regulate connexin hemichannels by modulating intrinsic voltage-dependent gating | Q36843197 | ||
| Remodelling of gap junctions and connexin expression in diseased myocardium. | Q36870641 | ||
| Connexin mimetic peptides inhibit Cx43 hemichannel opening triggered by voltage and intracellular Ca2+ elevation | Q36870663 | ||
| P2X7 receptors mediate ATP release and amplification of astrocytic intercellular Ca2+ signaling | Q36981083 | ||
| The N-terminal half of the connexin protein contains the core elements of the pore and voltage gates | Q37075368 | ||
| Loop gating of connexin hemichannels involves movement of pore-lining residues in the first extracellular loop domain | Q37094208 | ||
| Gap junction-mimetic peptides do work, but in unexpected ways | Q37130224 | ||
| Conformational changes in a pore-forming region underlie voltage-dependent "loop gating" of an unapposed connexin hemichannel | Q37268155 | ||
| Direct actions of carbenoxolone on synaptic transmission and neuronal membrane properties | Q37298719 | ||
| Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies | Q37375210 | ||
| GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype | Q37429017 | ||
| Potent block of Cx36 and Cx50 gap junction channels by mefloquine | Q37485123 | ||
| Voltage gating and permeation in a gap junction hemichannel | Q37558064 | ||
| Connexin-26 mutations in deafness and skin disease. | Q37638797 | ||
| Pharmacological and genetic approaches to study connexin-mediated channels in glial cells of the central nervous system | Q37644993 | ||
| Connexin Modulators and Their Potential Targets under the Magnifying Glass | Q37799642 | ||
| Role of gap junctions in epilepsy | Q37959793 | ||
| Glial hemichannels and their involvement in aging and neurodegenerative diseases | Q38002385 | ||
| Cisplatin and oxaliplatin inhibit gap junctional communication by direct action and by reduction of connexin expression, thereby counteracting cytotoxic efficacy | Q39730206 | ||
| Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in Xenopus oocytes. | Q40457389 | ||
| Inhibition of hERG K+ currents by antimalarial drugs in stably transfected HEK293 cells. | Q40598414 | ||
| Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells | Q40632649 | ||
| Besides affecting intracellular calcium signaling, 2-APB reversibly blocks gap junctional coupling in confluent monolayers, thereby allowing measurement of single-cell membrane currents in undissociated cells | Q40665591 | ||
| Fenamates: a novel class of reversible gap junction blockers. | Q40786159 | ||
| Long-chain n-alkanols and arachidonic acid interfere with the Vm-sensitive gating mechanism of gap junction channels | Q41068020 | ||
| Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. | Q41131251 | ||
| Permeation pathway of homomeric connexin 26 and connexin 30 channels investigated by molecular dynamics | Q41432409 | ||
| Interaction of anaesthetics with electrical synapses | Q41548926 | ||
| Interaction of Tetraethylammonium Ion Derivatives with the Potassium Channels of Giant Axons | Q41761074 | ||
| Analysis of effects of connexin-mimetic peptides in rat mesenteric small arteries | Q42489777 | ||
| Charges dispersed over the permeation pathway determine the charge selectivity and conductance of a Cx32 chimeric hemichannel | Q42649575 | ||
| Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG. | Q43740375 | ||
| Inhibition of gap junction hemichannels by chloride channel blockers | Q43916372 | ||
| Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26. | Q44277434 | ||
| Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid | Q44325495 | ||
| Closure of gap junction channels by arylaminobenzoates | Q44449947 | ||
| Carbenoxolone Blockade of Neuronal Network Activity in Culture is not Mediated by an Action on Gap Junctions | Q44599998 | ||
| Identification of Gap Junction Blockers Using Automated Fluorescence Microscopy Imaging | Q44624274 | ||
| Carbenoxolone inhibition of voltage-gated Ca channels and synaptic transmission in the retina | Q44804029 | ||
| A high-throughput assay for connexin 43 (Cx43, GJA1) gap junctions using codon-optimized aequorin | Q45309031 | ||
| Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships | Q46979453 | ||
| Reversible pore block of connexin channels by cyclodextrins | Q47881008 | ||
| Opposite voltage gating polarities of two closely related connexins | Q49110748 | ||
| Severe neuropathy with leaky connexin32 hemichannels. | Q50663082 | ||
| Volatile anesthetics block intercellular communication between neonatal rat myocardial cells. | Q51749593 | ||
| 2-aminoethoxydiphenyl borate directly inhibits channels composed of connexin26 and/or connexin32. | Q53589060 | ||
| Gap Junction Hemichannel Interactions with Zwitterionic Lipid, Anionic Lipid, and Cholesterol: Molecular Simulation Studies | Q60713726 | ||
| Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists | Q69843588 | ||
| Effect of several uncouplers of cell-to-cell communication on gap junction morphology in mammalian heart | Q71833680 | ||
| Connexin mimetic peptides reversibly inhibit Ca(2+) signaling through gap junctions in airway cells | Q72988595 | ||
| Cell-cell communication in heterocellular cultures of alveolar epithelial cells | Q73396905 | ||
| The role of gap junctions in seizures | Q73635204 | ||
| Peptides homologous to extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries | Q73677467 | ||
| Inhibition of volume-regulated and calcium-activated chloride channels by the antimalarial mefloquine | Q74326616 | ||
| Role of heterocellular Gap junctional communication in endothelium-dependent smooth muscle hyperpolarization: inhibition by a connexin-mimetic peptide | Q77911549 | ||
| Is connexin36 critical for GABAergic hypersynchronization in the hippocampus? | Q83386446 | ||
| Gap26, a connexin mimetic peptide, inhibits currents carried by connexin43 hemichannels and gap junction channels | Q83618373 | ||
| Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling | Q84094747 | ||
| P1104 | number of pages | 8 | |
| P304 | page(s) | 517-524 | |
| P577 | publication date | 2013-04-15 | |
| P1433 | published in | Neuropharmacology | Q15332439 |
| P1476 | title | Connexin channel modulators and their mechanisms of action | |
| P478 | volume | 75 |
| Q37724410 | A Cell-Based Assay to Assess Hemichannel Function |
| Q91665749 | A New Tool for In Vivo Study of Astrocyte Connexin 43 in Brain |
| Q91395203 | A Simple Assay to Evaluate the Function of Human Connexin Hemichannels Expressed in Escherichia coli that Can Be Used for Drug Discovery and Mutant Analysis |
| Q30557012 | A rapid and sensitive assay of intercellular coupling by voltage imaging of gap junction networks |
| Q41946636 | Aberrant connexin26 hemichannels underlying keratitis-ichthyosis-deafness syndrome are potently inhibited by mefloquine |
| Q42057370 | Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases. |
| Q55174378 | Connexin32 plays a crucial role in ROS-mediated endoplasmic reticulum stress apoptosis signaling pathway in ischemia reperfusion-induced acute kidney injury. |
| Q47770967 | Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications |
| Q35832943 | Critical role of gap junction communication, calcium and nitric oxide signaling in bystander responses to focal photodynamic injury. |
| Q36015504 | Descending Vasa Recta Endothelial Membrane Potential Response Requires Pericyte Communication |
| Q49047593 | Electroporation Loading and Dye Transfer: A Safe and Robust Method to Probe Gap Junctional Coupling. |
| Q57189470 | Ephaptic Coupling Promotes Synchronous Firing of Cerebellar Purkinje Cells |
| Q33921091 | Extensive astrocyte synchronization advances neuronal coupling in slow wave activity in vivo |
| Q35207242 | Functional hemichannels formed by human connexin 26 expressed in bacteria |
| Q47351402 | Inhibition by Commercial Aminoglycosides of Human Connexin Hemichannels Expressed in Bacteria |
| Q90076774 | Inhibition of gap junctional intercellular communication by an anti-migraine agent, flunarizine |
| Q34138968 | Innexin AGAP001476 is critical for mediating anti-Plasmodium responses in Anopheles mosquitoes |
| Q47215575 | Molecular basis for potentiation of Cx36 gap junction channel conductance by n-alcohols and general anesthetics |
| Q42323019 | On Biophysical Properties and Sensitivity to Gap Junction Blockers of Connexin 39 Hemichannels Expressed in HeLa Cells |
| Q26738433 | Purinergic Signaling in Gut Inflammation: The Role of Connexins and Pannexins |
| Q42174799 | Recurrent seizure-like events are associated with coupled astroglial synchronization |
| Q30406156 | Regulation of cellular communication by signaling microdomains in the blood vessel wall |
| Q52627188 | Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone. |
| Q28550067 | Simvastatin Sodium Salt and Fluvastatin Interact with Human Gap Junction Gamma-3 Protein |
| Q39154696 | Synchrony and so much more: Diverse roles for electrical synapses in neural circuits |
| Q34528370 | The Role of the Mucosa in Normal and Abnormal Bladder Function |
| Q90365645 | The connexin26 human mutation N14K disrupts cytosolic intersubunit interactions and promotes channel opening |
| Q41415423 | The double life of connexin channels: single is a treat |
Search more.